510(k) Report

510(k) · Cleared

Recalled · Class II · 2016

The Cellfina System

K161885510(k) TraditionalCleared Oct 5, 201686-day reviewClass II21 CFR 878.4790Recalls 1

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Ulthera, Inc. · OUP Powered Surgical Instrument For Improvement In The Appearance Of Cellulite

Cleared on Oct 5, 2016 as substantially equivalent to K153677 (Ulthera, Inc., 2016) after an 86-day review. Its family tree reaches back 4 generations to 2013. 4 later devices descend from it. It has been recalled once.

Decided
Oct 5, 2016
Review
86 days
Class
Class II
Product code
OUP
Recalls
1
Predicates
1

Its longest line of descent runs back 4 generations to DEN110004 (2013). 4 later devices descend from it, 1 citing it directly.

Descendants, by year cleared 2019: 1 descendant cleared2021: 1 descendant cleared2022: 1 descendant cleared2023: 1 descendant clearedDEN110004 · Cabochon System · Cabochon Aesthetics, Inc. · 2013K134010 · Cabochon System · Cabochon Aesthetics, Inc. · 2014K150505 · Cellfina System · Ulthera, Inc. · 2015K153677 · The Cellfina System · Ulthera, Inc. · 20162010201520202025
Descendants, by generation 1 generation forward: 1 descendant2 generations forward: 1 descendant3 generations forward: 1 descendant4 generations forward: 1 descendant K153677 · The Cellfina System · Ulthera, Inc. · 2016K150505 · Cellfina System · Ulthera, Inc. · 2015K134010 · Cabochon System · Cabochon Aesthetics, Inc. · 2014DEN110004 · Cabochon System · Cabochon Aesthetics, Inc. · 20130
  1. Root · 4 generations backDEN110004 Cabochon SystemCabochon Aesthetics, Inc. · 2013
  2. 3 generations backK134010 Cabochon SystemCabochon Aesthetics, Inc. · 2014
  3. 2 generations backK150505 Cellfina SystemUlthera, Inc. · 2015
  4. 1 generation backK153677 The Cellfina SystemUlthera, Inc. · 2016
  5. This deviceK161885 The Cellfina SystemUlthera, Inc. · 2016
  6. Descendant · cites it directly · 3 of its ownK192185 The Cellfina SystemUlthera, Inc. · 2019
  7. Descendant · 2 generations on · 2 of its ownK212399 AveliNc8, Inc. · 2021
  8. Descendant · 3 generations on · 1 of its ownK221336 AvéliRevelle Aesthetics, Inc. · 2022
  9. Descendant · 4 generations on · 0 of its ownK232153 AvéliRevelle Aesthetics, Inc. · 2023

Most influential descendants

Showing 4 of 4 · See all
  • K192185The Cellfina SystemUlthera, Inc. · 2019 · cites it directly3descendants
  • K212399AveliNc8, Inc. · 2021 · 2 generations on2descendants
  • K221336AvéliRevelle Aesthetics, Inc. · 2022 · 3 generations on1descendant
  • K232153AvéliRevelle Aesthetics, Inc. · 2023 · 4 generations on0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−4DEN110004Cabochon SystemCabochon Aesthetics, Inc.2013—
−3K134010Cabochon SystemCabochon Aesthetics, Inc.2014—
−2K150505Cellfina SystemUlthera, Inc.2015—
−1K153677The Cellfina SystemUlthera, Inc.2016—
0 (this device)K161885The Cellfina SystemUlthera, Inc.2016—
+1K192185The Cellfina SystemUlthera, Inc.2019—
+2K212399AveliNc8, Inc.2021—
+3K221336AvéliRevelle Aesthetics, Inc.2022—
+4K232153AvéliRevelle Aesthetics, Inc.2023—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201910
202110
202210
202310
FIG. 1 — Lineage of K161885, 2013–2023Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in OUP? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new OUP device

  1. #1 K221336 Avéliscore 8.6 · 7 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K153677The Cellfina System
Summary page 4
…of cellulite. Regulation Number: 21CFR 878.4790 Product Code: OUP Legally Marketed Predicate: The Cellfina System, 510(k): K153677 Applicable Guidance: The following guidance special controls are applicable to the Cellfi…
Ulthera, Inc.2016—

What descends from it? (4)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K192185The Cellfina SystemUlthera, Inc.20193

Has anything in its family been recalled? (0 Class I)

Recalls of this device

DateClassRecallRoot causeReason
Nov 14, 2016Class IIZ-0749-2017OtherIt was discovered that a non-sterile vacuum tube is supplied within the pack, although the Instructions for Use (IFU) describe the use of a sterile vacuum tube as part of the procedure setup.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 3 years and passes through 2 companies; a new generation was cleared every 9 months on median.
  • None of the 4 ancestors has a recall.
  • Of its descendants, K192185 (Ulthera, Inc., 2019) has gone furthest, with 3 descendants of its own.

How does its category compare?

All OUP devices

OUP Powered Surgical Instrument For Improvement In The Appearance Of Cellulite: FDA decisions, review times, recalls and adverse event reports over 20 years. 2016, this device’s year, is highlighted.

FDA decisions per year · OUP

1in 2023

2013: 12014: 12015: 12016: 22019: 12021: 12022: 12023: 1
2007high 2 (2016) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · OUP

Too few OUP 510(k)s in any year since 2007 to give a median.

Recalls per year · OUP

1in 2016

2016: 1
2007high 1 (2016) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · OUP

4in 2025

2016: 32017: 42018: 82019: 162020: 32021: 92022: 152023: 112024: 62025: 4
2007high 16 (2019) · low 0 (2007)2025

MAUDE reports naming product code OUP, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—00
20110—00
20120—00
20131—00
20141—00
20151—00
20162—13
20170—04
20180—08
20191—016
20200—03
20211—09
20221—015
20231—011
20240—06
20250—04
20260—0—

What is it indicated for?

The Cellfina™ System is intended for long term improvement in the appearance of cellulite in the buttocks and thigh areas of adult females as supported by clinical data demonstrating no significant reduction in treatment benefits up to 3 years of observation.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K161885: The Cellfina System.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K161885

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026